Clinical Trials Directory

Trials / Completed

CompletedNCT03009513

Teneligliptin-Glimepiride DDI Study

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Handok Inc. · Industry
Sex
Male
Age
20 Years – 45 Years
Healthy volunteers
Accepted

Summary

An open label, one sequence study to investigate the pharmacokinetic drug interaction between Teneligliptin and Glimepiride in healthy male subjects

Conditions

Interventions

TypeNameDescription
DRUGTeneligliptin+Glimepiride

Timeline

Start date
2017-01-01
Primary completion
2017-05-01
Completion
2017-06-01
First posted
2017-01-04
Last updated
2018-05-02

Source: ClinicalTrials.gov record NCT03009513. Inclusion in this directory is not an endorsement.

Teneligliptin-Glimepiride DDI Study (NCT03009513) · Clinical Trials Directory